Collaboration is key to driving the best science. At the Parker Institute, we partner with industry and nonprofit organizations to help us elevate every cancer immunotherapy research project and clinical trial. We talked with Ilan Zipkin, our VP of Business Development, about how we bridge the gap between academia and industry to get much needed treatments to patients faster.
Here’s a short overview of the video:
When we talk about business development at the Parker Institute, we’re talking about collaborations and partnerships – with our member researchers, other nonprofits, and especially companies across the entire range of the biotech and pharma industry.
Working with these partners gives us the opportunity to push the boundaries in cancer therapy in innovative ways that wouldn’t happen without the collaborative effort of multiple parties coming together through the Parker Institute.